Workflow
达利凯普(301566) - 301566达利凯普投资者关系活动记录表20250624

Financial Performance - In 2024, the company's operating revenue was 32,334.13 million RMB, a decrease of 6.47% compared to the previous year [2] - The net profit attributable to shareholders, excluding non-recurring gains and losses, decreased by 0.58% year-on-year, with a slower decline compared to 2023 [2] - In Q1 2025, operating revenue reached 10,083.99 million RMB, representing a growth of 25.31% year-on-year [2] - The net profit attributable to shareholders in Q1 2025 increased by 58.78% compared to the same period last year [2] Research and Development - As of 2024, the company employed 342 staff, with R&D personnel accounting for 13.45% of the total [3] - R&D investment amounted to 6.88% of operating revenue, an increase of 1.63% from the previous year [3] Dividend Policy - The profit distribution plan for 2024 involved a cash dividend of 0.6 RMB per 10 shares, totaling 2,400.06 million RMB distributed to shareholders [4] - The cash dividends were transferred to shareholders' accounts on May 30, 2025 [4] Client Base - The company collaborates with major manufacturers in various sectors, including mobile communication base stations, medical imaging, military equipment, rail transit signal equipment, and semiconductor RF power [5] - Notable clients include GE Healthcare, Siemens Healthineers, and China Communications Technology [5] Growth Strategy - The company aims to become a world-class supplier of high-end electronic components, focusing on R&D and quality [6] - Plans include enhancing production efficiency, expanding capacity, and improving supply chain capabilities to increase market share [6] Performance Drivers - Q1 2025 performance growth was primarily driven by sectors such as semiconductor RF power, medical, and military industries [6] - The company emphasizes innovation and digitalization to enhance manufacturing processes and customer satisfaction [6]